Teva Pharmaceutical Industries Ltd. (TEVJF)
37.00
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Teva Pharmaceutical Industries Enterprise Value : 56.33B for Sept. 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 56.33B |
| September 01, 2026 | 56.33B |
| August 31, 2026 | 56.33B |
| August 28, 2026 | 56.33B |
| August 27, 2026 | 56.33B |
| August 26, 2026 | 56.33B |
| August 25, 2026 | 56.33B |
| August 24, 2026 | 56.33B |
| August 21, 2026 | 56.33B |
| August 20, 2026 | 56.33B |
| August 19, 2026 | 56.33B |
| August 18, 2026 | 56.33B |
| August 17, 2026 | 56.33B |
| August 14, 2026 | 56.33B |
| August 13, 2026 | 56.33B |
| August 12, 2026 | 56.33B |
| August 11, 2026 | 46.31B |
| August 10, 2026 | 46.31B |
| August 07, 2026 | 46.31B |
| August 06, 2026 | 46.31B |
| August 05, 2026 | 46.31B |
| August 04, 2026 | 46.31B |
| August 03, 2026 | 46.31B |
| July 31, 2026 | 46.31B |
| July 30, 2026 | 46.31B |
| Date | Value |
|---|---|
| July 29, 2026 | 46.31B |
| July 28, 2026 | 46.31B |
| July 27, 2026 | 46.31B |
| July 24, 2026 | 46.31B |
| July 23, 2026 | 46.31B |
| July 22, 2026 | 46.31B |
| July 21, 2026 | 46.31B |
| July 20, 2026 | 51.67B |
| July 17, 2026 | 51.67B |
| July 16, 2026 | 51.67B |
| July 15, 2026 | 51.67B |
| July 14, 2026 | 51.67B |
| July 13, 2026 | 51.67B |
| July 10, 2026 | 51.67B |
| July 09, 2026 | 51.67B |
| July 08, 2026 | 51.67B |
| July 07, 2026 | 51.67B |
| July 06, 2026 | 51.67B |
| July 02, 2026 | 51.67B |
| July 01, 2026 | 51.67B |
| June 30, 2026 | 48.57B |
| June 29, 2026 | 48.49B |
| June 26, 2026 | 48.49B |
| June 25, 2026 | 48.49B |
| June 24, 2026 | 48.49B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 142.80M |
| Purple Biotech Ltd. | -2.825M |
| Sol-Gel Technologies Ltd. | 183.43M |
| PolyPid Ltd. | 102.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -576.00M |
| Revenue (Quarterly) | 4.15B |
| Total Expenses (Quarterly) | 4.726B |
| EPS Diluted (Quarterly) | -0.4944 |
| Gross Profit Margin (Quarterly) | 52.07% |
| Profit Margin (Quarterly) | -13.88% |
| Earnings Yield | 1.62% |
| Operating Earnings Yield | 7.54% |
| Normalized Earnings Yield | 4.283 |